Cengild Medical Berhad (KLSE:CENGILD)

Malaysia · Delayed Price · Currency is MYR

0.1550

-0.0050 (-3.13%)

At close: Nov 3, 2026

Market Cap	129.10M -31.1%
Revenue (ttm)	73.21M -8.5%
Net Income	11.44M +3.5%
EPS	0.01 +3.2%
Shares Out	832.91M
PE Ratio	11.31
Forward PE	n/a
Dividend	0.00 (2.32%)
Ex-Dividend Date	Sep 11, 2026

Volume	453,900
Open	0.1550
Previous Close	0.1600
Day's Range	0.1500 - 0.1550
52-Week Range	0.1300 - 0.2500
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric su... [Read more]

Industry Health Services

Founded 2017

Employees 151

Stock Exchange Bursa Malaysia

Ticker Symbol CENGILD

Full Company Profile

Financial Performance

In fiscal year 2026, Cengild Medical Berhad's revenue was 73.21 million, a decrease of -8.49% compared to the previous year's 80.00 million. Earnings were 11.44 million, an increase of 3.47%.

Financial Statements